norfloxacin has been researched along with sulfamethoxazole in 73 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (54.79) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (9.59) | 29.6817 |
| 2010's | 15 (20.55) | 24.3611 |
| 2020's | 11 (15.07) | 2.80 |
| Authors | Studies |
|---|---|
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Awuah, E; Barker, C; Brown, ED; Capretta, FA; Das, R; Gerritsma, DA; Lebert, J; Melacini, G; Pathania, R; Zlitni, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Guo, H | 1 |
| Li, S; Maddili, SK; Sun, H; Yang, RG; Yang, X; Zhou, CH | 1 |
| Bheemanaboina, RRY; Deng, Z; Luo, Y; Sun, H; Zhou, CH | 1 |
| Berry, SJ; Gotuzzo, E; Guzman, M; Leon-Barua, R; Maguiña, C; Oberhelman, RA; Ruiz, R; Sack, RB; Yi, A | 1 |
| Boerema, JB | 1 |
| Bartlett, J; Champlin, RE; Deresinski, S; Finley, RS; Ho, WG; Joshi, JH; Karp, J; Levitt, L; Talbot, G; Winston, DJ | 1 |
| Kawaguchi, K; Yamaguchi, K | 1 |
| Chan, MK; Cheng, IK; Li, MK; Wong, WS; Wong, WT; Yin, PD | 1 |
| Chongthaleong, A; Petcharabutr, OA; Sitprija, V; Tungsanga, K; Udomsantisuk, N; Wong, EC | 1 |
| Lolekha, S; Patanachareon, S; Thanangkul, B; Vibulbandhitkit, S | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Benbachir, M; el Filali, KM; el Mdaghri, N; Hajji, M; Himmich, H | 1 |
| Schaeffer, AJ; Sisney, GA | 1 |
| Hoagland, VL; Sabbaj, J; Shih, WJ | 1 |
| Alpert, ML; Ginsberg, BP; Goldstein, EJ | 1 |
| Fontana, R; Meloni, GA; Rossi, L | 1 |
| Dubini, F; Riviera, L | 2 |
| Corrado, ML; Hesney, M; Struble, WE | 1 |
| Bow, EJ; Louie, TJ; Rayner, E | 1 |
| Alpert, ML; Cherubin, CE; Eng, RH; Ginsburg, BP; Goldstein, EJ; Kahn, RM; Najem, A | 1 |
| Corrado, ML; Dupont, HL; Sabbaj, J | 1 |
| Boyko, EJ; Cox, CE; Goldstein, EJ; Kurtz, TO; Miller, K; Mummaw, N; Reller, LB; Stein, GE | 1 |
| Norrby, SR; Rylander, M; Svärd, R | 1 |
| Dubini, F; Riviera, L; Visconti, A | 1 |
| Cook, T; Hoagland, VL; Sabbaj, J | 1 |
| Dournon, E; Rajagopalan, P; Vildé, JL | 1 |
| Bille, J; Darioli, R; de Vevey, P; Glauser, MP | 1 |
| Albini, E; Belluco, G; Marca, G | 1 |
| Borsotto, M; Carlone, NA; Cuffini, AM; Savoia, D | 1 |
| Abruzzo, GK; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Pelak, BA | 1 |
| Drusano, GL; Morris, JG; Tenney, JH | 1 |
| Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
| Antunez de Mayolo, E; Benavente, L; Falconi, E; Guerra, JG; Palomino, JC | 1 |
| Daikos, GK; Giamarellou, H; Petrikkos, G; Tsagarakis, J | 1 |
| Barry, AL; Jones, RN | 1 |
| Currie, WJ; Deaney, NB; Round, EM; VandenBurg, MJ; Vogel, R | 1 |
| Newsom, SW | 1 |
| Bendall, MJ | 1 |
| Chait, I; Deaney, NB; Kelsey, MC; Newsom, RA; Newsom, SW; Round, EM; Smith, J; Toase, PD; Vogel, R; Watt, B | 1 |
| Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
| Haase, DA; Harding, GK; Kennedy, JK; Ronald, AR; Thomson, MJ; Urias, BA | 1 |
| Arroyo, V; Colmenero, J; Fernández, J; Gómez, J; Navasa, M; Rodés, J; Vila, J | 1 |
| Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V | 1 |
| Amábile-Cuevas, CF; Arredondo-García, JL; Cardeñosa-Guerra, O; Corral, M; Costa, A; Figueroa-Damián, R; Hernández-Oliva, GM; Jáuregui, A; Merlos, RM; Olguín, J; Ríos-Fabra, A; Rosas, A | 1 |
| Kato, S; Le, TX; Munekage, Y | 1 |
| Depta, JP; Lüthi, M; Pichler, WJ; Schmid, DA | 1 |
| Brown, ED; Farha, MA | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Herodes, K; Kipper, K; Leito, I; Nei, L | 1 |
| Liu, J; Lu, G; Wu, D; Yan, Z | 1 |
| Fu, J; Lin, H; Ma, J; Qian, M; Sun, W; Wang, J; Wu, H; Xia, Y; Zhang, Z | 1 |
| Li, H; Liang, N; Pan, B; Wu, M; Zhang, D; Zheng, N | 1 |
| Liu, J; Lu, G; Yan, Z; Ye, Q | 1 |
| Huang, Z; Li, S; Liao, QJ; Liu, YQ; Luo, R; Shang, JG; Wang, Y | 1 |
| Cheng, JS; Gao, N; Liu, CX; Xu, QM; Yuan, YJ | 1 |
| Cai, L; Feng, Y; Li, B; Wang, Y; Xu, X; Yu, M; Zhang, H | 1 |
| Lv, Z; Na, J; Niu, Z; Xu, W; Zhang, Y | 1 |
| De Oliveira, T; Guégan, R; Le Gleuher, J; Sugahara, Y | 1 |
| Abebe, N; Ahmed, M; Awol, N; Bsrat, A; Gugsa, G; Hagos, Y; Tsegaye, Y | 1 |
| Deng, J; Pan, Z; Rong, C; Shao, Y; Zhang, Y; Zhu, Y | 1 |
| Arsand, JB; Jank, L; Pizzolato, TM; Schwalm, CS; Segalin, J; Streit, L | 1 |
| Bai, H; Chen, J; Gao, FZ; He, LX; He, LY; Hu, LX; Liu, YS; Yang, YY; Ying, GG; Zhao, JL | 1 |
| Cao, Z; Li, X; Lu, Y; Mao, R; Song, S; Sun, B; Wang, C; Wang, R; Zhang, M | 1 |
| Chen, H; Di, X; Ding, J; Lin, J; Sun, W; Zhang, H | 1 |
| Chen, Y; Cui, K; Ding, Y; Liu, X; Qin, X | 1 |
| Cruz-Monzon, J; De La Cruz-Noriega, M; Gallozzo Cardenas, M; Gamez-Jara, A; Rodríguez-Serin, H; Rodriguez-Yupanqui, M; Rojas-Flores, S | 1 |
3 review(s) available for norfloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
A review of urinary tract infection in the elderly.
Topics: Aged; Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Literature Review: Evaluation of Drug Removal Techniques in Municipal and Hospital Wastewater.
Topics: Anti-Bacterial Agents; Carbamazepine; Diclofenac; Hospitals; Naproxen; Norfloxacin; Ofloxacin; Ozone; Pharmaceutical Preparations; Sewage; Sulfamethoxazole; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2022 |
24 trial(s) available for norfloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
Topics: Adult; Clinical Trials as Topic; Diarrhea; Drug Combinations; Dysentery, Bacillary; Feces; Humans; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Norfloxacin; Random Allocation; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Humans; Middle Aged; Mycoses; Norfloxacin; Polymyxins; Random Allocation; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
Treatment of urinary tract infections in Hong Kong: a comparative study of norfloxacin and co-trimoxazole.
Topics: Adult; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Hong Kong; Humans; Male; Middle Aged; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1988 |
Norfloxacin versus co-trimoxazole for the treatment of upper urinary tract infections: a double blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1988 |
Norfloxacin versus co-trimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study.
Topics: Acute Disease; Adult; Bacterial Infections; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.
Topics: Adult; Drug Combinations; Female; Humans; Male; Norfloxacin; Paratyphoid Fever; Pefloxacin; Prospective Studies; Random Allocation; Salmonella paratyphi A; Salmonella paratyphi B; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1988 |
Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
Topics: Adult; Anal Canal; Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vagina | 1985 |
Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
Topics: Adult; Bacteria; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
Topics: Adult; Drug Combinations; Female; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestinal Diseases; Humans; Leukemia; Neutropenia; Norfloxacin; Skin Diseases; Sulfamethoxazole; Trimethoprim; Vancomycin | 1988 |
Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Female; Gram-Negative Bacteria; Humans; Leukemia; Male; Neutropenia; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Norfloxacin; Prospective Studies; Random Allocation; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Use of norfloxacin in the treatment of acute diarrheal disease.
Topics: Acute Disease; Adult; Child; Clinical Trials as Topic; Diarrhea; Drug Combinations; Feces; Humans; Microbial Sensitivity Tests; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Norfloxacin; Pyuria; Random Allocation; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1987 |
Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Norfloxacin; Prospective Studies; Random Allocation; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Humans; Male; Microbial Sensitivity Tests; Norfloxacin; Prostatitis; Random Allocation; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
[Comparative study of the treatment of simple urinary infection with a single dose of norfloxacin versus cotrimoxazole].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Humans; Middle Aged; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1983 |
Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1983 |
Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Bacteria; Drug Administration Schedule; Drug Combinations; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
Topics: Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Feces; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urethra; Urinary Tract Infections | 1984 |
Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Latin America; Norfloxacin; Premenopause; Prospective Studies; Sulfamethoxazole; Time Factors; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2004 |
46 other study(ies) available for norfloxacin and sulfamethoxazole
| Article | Year |
|---|---|
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.
Topics: Anti-Bacterial Agents; Cell Division; Chromatography, Liquid; Cycloserine; Doxorubicin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Genes, Bacterial; Genome, Bacterial; Genomics; Lipoproteins; Mass Spectrometry; Molecular Chaperones; Periplasmic Binding Proteins; Pseudomonas aeruginosa; Sulfamethoxazole; Suppression, Genetic; Trimethoprim | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Dihydropyrimidinone imidazoles as unique structural antibacterial agents for drug-resistant gram-negative pathogens.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Humans; Imidazoles; Microbial Sensitivity Tests; Norfloxacin | 2022 |
Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
Topics: Anthraquinones; Anti-Bacterial Agents; Enterococcus faecalis; Humans; Intercalating Agents; Sulfanilamide | 2022 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxacin; Prostatitis; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1986 |
[Single day treatment in acute cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cystitis; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Humans; Middle Aged; Norfloxacin; Ofloxacin; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens.
Topics: Bacteria; Drug Combinations; Drug Resistance, Microbial; Fosfomycin; Humans; Microbial Sensitivity Tests; Mutation; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Urine | 1988 |
Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
Topics: Administration, Oral; Adolescent; Adult; Bacteria; Cystitis; Drug Combinations; Fosfomycin; Humans; Male; Models, Biological; Norfloxacin; Pipemidic Acid; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 1988 |
Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol.
Topics: Administration, Oral; Animals; Bacterial Infections; Cystitis; Drug Combinations; Fosfomycin; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol].
Topics: Animals; Cystitis; Drug Combinations; Drug Evaluation, Preclinical; Escherichia coli Infections; Fosfomycin; Klebsiella Infections; Norfloxacin; Pipemidic Acid; Proteus Infections; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.
Topics: Anti-Bacterial Agents; Doxycycline; Drug Combinations; Erythromycin; Humans; Legionella; Macrophages; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Pefloxacin; Rifampin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
Topics: Culture Media; Drug Combinations; Escherichia coli; Fosfomycin; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 1986 |
Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents.
Topics: Bacterial Adhesion; Drug Combinations; Escherichia coli; Fosfomycin; Hemagglutination; Humans; Microbial Sensitivity Tests; Norfloxacin; Proteus mirabilis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Infective Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Combinations; Escherichia coli Infections; Female; Mice; Mice, Inbred Strains; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
Topics: Ampicillin; Chloramphenicol; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio | 1985 |
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Digestive System; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
Topics: Acinetobacter; Anti-Infective Agents, Urinary; Bacteria; Cinoxacin; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pseudomonas; Pseudomonas aeruginosa; Quality Control; Reference Standards; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
The antimicrobial spectrum of norfloxacin.
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Hepatitis C; Humans; Kidney; Liver; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Sulfamethoxazole; Trimethoprim | 2002 |
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2003 |
Antibiotic resistance in bacteria from shrimp farming in mangrove areas.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Aquaculture; Bacteria; Biodegradation, Environmental; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Environmental Monitoring; Geologic Sediments; Norfloxacin; Oxolinic Acid; Penaeidae; Sulfamethoxazole; Trimethoprim; Vietnam; Water Microbiology; Water Pollutants, Chemical | 2005 |
Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
Topics: Animals; B-Lymphocytes; CD3 Complex; CD4 Antigens; Cell Line, Transformed; Cells, Cultured; Ciprofloxacin; Cross Reactions; Drug Interactions; Flow Cytometry; Humans; Hybridomas; Interleukin-2; Mice; Norfloxacin; Quinolones; Receptors, Antigen, T-Cell; Sulfamethizole; Sulfamethoxazole; Sulfanilamides; T-Lymphocytes; Time Factors; Transfection | 2006 |
Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity.
Topics: Anti-Infective Agents; Cell Membrane; Cluster Analysis; Drug Evaluation, Preclinical; Drug Synergism; Escherichia coli; Folic Acid; Norfloxacin; Sulfamethoxazole; Tetrahydrofolate Dehydrogenase; Topoisomerase II Inhibitors | 2010 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Two fluoroalcohols as components of basic buffers for liquid chromatography electrospray ionization mass spectrometric determination of antibiotic residues.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Lactuca; Mass Spectrometry; Norfloxacin; Ofloxacin; Propanols; Spectrometry, Mass, Electrospray Ionization; Sulfadimethoxine; Sulfamethoxazole | 2011 |
A multi-biomarker assessment of single and combined effects of norfloxacin and sulfamethoxazole on male goldfish (Carassius auratus).
Topics: Acetylcholinesterase; Animals; Biomarkers; Brain; Cytochrome P-450 CYP1A1; DNA Damage; Enzyme Activation; Glutathione Transferase; Goldfish; Gonads; Liver; Male; Norfloxacin; Sulfamethoxazole; Vitellogenins; Water Pollutants, Chemical | 2014 |
Variations in the fate and biological effects of sulfamethoxazole, norfloxacin and doxycycline in different vegetable-soil systems following manure application.
Topics: Anti-Bacterial Agents; Brassica; Doxycycline; Manure; Norfloxacin; Raphanus; Soil Microbiology; Soil Pollutants; Sulfamethoxazole; Vegetables | 2016 |
Adsorption mechanism of different organic chemicals on fluorinated carbon nanotubes.
Topics: Adsorption; Benzhydryl Compounds; Halogenation; Nanotubes, Carbon; Norfloxacin; Ofloxacin; Phenanthrenes; Phenols; Polytetrafluoroethylene; Sulfamethoxazole; Thermodynamics | 2016 |
Long-term effects of antibiotics, norfloxacin, and sulfamethoxazole, in a partial life-cycle study with zebrafish (Danio rerio): effects on growth, development, and reproduction.
Topics: Animals; Anti-Bacterial Agents; Cytochrome P-450 CYP1A1; Female; Life Cycle Stages; Norfloxacin; Reproduction; Sulfamethoxazole; Time Factors; Zebrafish | 2016 |
Migration of two antibiotics during resuspension under simulated wind-wave disturbances in a water-sediment system.
Topics: Adsorption; Anti-Bacterial Agents; China; Geologic Sediments; Lakes; Norfloxacin; Sulfamethoxazole; Suspensions; Water; Water Pollutants, Chemical; Wind | 2018 |
Simultaneous removal of ciprofloxacin, norfloxacin, sulfamethoxazole by co-producing oxidative enzymes system of Phanerochaete chrysosporium and Pycnoporus sanguineus.
Topics: Anti-Bacterial Agents; Biotransformation; Ciprofloxacin; Coculture Techniques; Norfloxacin; Oxidation-Reduction; Oxidative Stress; Phanerochaete; Pycnoporus; Sulfamethoxazole | 2018 |
Bio-Electron-Fenton (BEF) process driven by sediment microbial fuel cells (SMFCs) for antibiotics desorption and degradation.
Topics: Anti-Bacterial Agents; Biodegradation, Environmental; Bioelectric Energy Sources; Hydrogen Peroxide; Iron; Norfloxacin; Oxidation-Reduction; Sulfamethoxazole; Wastewater; Water Pollutants, Chemical | 2019 |
How long-term exposure of environmentally relevant antibiotics may stimulate the growth of Prorocentrum lima: A probable positive factor for red tides.
Topics: Anti-Bacterial Agents; Antioxidants; Catalase; Chlorella; Dinoflagellida; Ecosystem; Harmful Algal Bloom; Norfloxacin; Peroxidase; Peroxidases; Sulfamethoxazole; Superoxide Dismutase; Time Factors; Water Pollutants | 2019 |
Tuning down the environmental interests of organoclays for emerging pollutants: Pharmaceuticals in presence of electrolytes.
Topics: Adsorption; Amoxicillin; Carbamazepine; Cations; Electrolytes; Environmental Restoration and Remediation; Hydrophobic and Hydrophilic Interactions; Metoprolol; Norfloxacin; Pharmaceutical Preparations; Soil; Soil Pollutants; Sulfamethoxazole; Trimethoprim; Water; Water Pollutants, Chemical; X-Ray Diffraction | 2020 |
Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Chloramphenicol; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Erythromycin; Ethiopia; Goats; Meat; Microbial Sensitivity Tests; Norfloxacin; Prevalence; Streptomycin; Sulfamethoxazole; Trimethoprim | 2021 |
Toxicity of disinfection byproducts formed during the chlorination of sulfamethoxazole, norfloxacin, and 17β-estradiol in the presence of bromide.
Topics: Bromides; Disinfectants; Disinfection; Estradiol; Halogenation; Norfloxacin; Sulfamethoxazole; Water Pollutants, Chemical; Water Purification | 2021 |
In silico toxicity evaluation for transformation products of antimicrobials, from aqueous photolysis degradation.
Topics: Anti-Infective Agents; Ciprofloxacin; Mutagens; Norfloxacin; Photolysis; Sulfamethoxazole; Water; Water Pollutants, Chemical | 2022 |
The variations of antibiotics and antibiotic resistance genes in two subtropical large river basins of south China: Anthropogenic impacts and environmental risks.
Topics: Anthropogenic Effects; Anti-Bacterial Agents; China; Chlortetracycline; Drug Resistance, Microbial; Ecosystem; Enrofloxacin; Genes, Bacterial; Norfloxacin; Ofloxacin; Oxytetracycline; Rivers; RNA, Ribosomal, 16S; Sulfamethoxazole; Sulfonamides; Water | 2022 |
Contamination, transport, and ecological risks of pharmaceuticals and personal care products in a large irrigation region.
Topics: Caffeine; China; Cosmetics; Ecosystem; Environmental Monitoring; Erythromycin; Humans; Norfloxacin; Ofloxacin; Pharmaceutical Preparations; Risk Assessment; Sulfamethoxazole; Water Pollutants, Chemical | 2022 |
Association between prenatal antibiotics exposure and measures of fetal growth: A repeated-measure study.
Topics: Anti-Bacterial Agents; Birth Weight; Ciprofloxacin; Female; Fetal Development; Humans; Infant, Newborn; Maternal Exposure; Norfloxacin; Pregnancy; Premature Birth; Sulfamethoxazole; Tandem Mass Spectrometry | 2022 |
A high-precision prediction for spatiotemporal distribution and risk assessment of antibiotics in an urban watershed using a hydrodynamic model.
Topics: Anti-Bacterial Agents; China; Enrofloxacin; Environmental Monitoring; Erythromycin; Humans; Hydrodynamics; Manure; Norfloxacin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sewage; Sulfamethoxazole; Water Pollutants, Chemical | 2022 |